Jeff Keelan

ACADEMIC POSITIONS: • Head of School of Biomedical Sciences, QEII Medical Centre, Nedlands, Perth • Winthrop Research Professor, Division of Obstetrics & Gynaecology, University of Western Australia, Perth WA • Head, Women and Infants Health Research Laboratory (WIHRL), King Edward Memorial Hospital, Perth, WA • Director, Women and Newborn Health Research Network (WNHRN), King Edward Memorial Hospital, Perth, WA • Deputy Director, Women and Infants Research Foundation (WIRF) • Honorary Research Associate, Telethon Kids Institute • Adjunct Professor, Curtin University • Board Member, Marshall Centre Advisory Board EDUCATION: • 1979: BSc (Hons) in Applied Biology, Liverpool John Moores University, UK • 1986: MSc (Hons 1st class) in Biochemistry, University of Auckland, NZ • 1994: PhD in Obstetrics & Gynaecology, University of Auckland, NZ MEMBERSHIPS (INCLUDING EDITORIAL): • Founding Member, ANZPRA (Australia and New Zealand Placental Research Association), 1999 • Member, International Federation of Placental Associations (IFPA; 1997-present) • Member, Society for Reproductive Biology (SRB), 2003-present • President, ANZPRA 2003-2007 • Member, Society for Gynecologic Investigation (SGI; 2000-present) • Member, Australian Society for Medical Research, May 2008–present • Member, Perinatal Society of Australia and New Zealand, October 2009–present • Member, American Nano Society, June 2011–present • Member, American Society for Microbiology, July 2011–present • Fellow, Society of Reproductive Biology, October 2011–present • Associate Editor, Reproduction, Fertility & Development, 2009-present • Associate Editor, Journal of Pregnancy, 2010–present • Editorial Board Member, Trophoblast Research, 2010-present • Associate Editor, Journal of Women’s Health, 2010-present RESEARCH INTERESTS: • Intrauterine infection, inflammation and the causes of preterm labour • Cytokines and prostaglandins in normal and preterm labour • Anti-inflammatory therapeutic strategies involving inhibition of NF-kappaB for prevention of inflammation-associated preterm labour • Role of activin and other members of the TGF-beta super-family as regulators of placental endocrine and immune function • Cytokine-induced fetal membrane apoptosis and its role in premature rupture of membranes • Prostaglandins as PPAR-gamma ligands and their role in placental apoptosis and NF-kappaB inhibitors • Placental drug transport and the role of drug efflux pumps in protection of the fetus and placenta from harmful drugs and endogenous compounds • ABC transporters in placental differentiation, toxicology and apoptosis • Lysophospholipids as novel autocrine regulators of placental growth, differentiation and function • Lysophospholipids and myometrial contractility • Placental mesenchymal stem cells • Anti-inflammatory lipid mediators derived from omega-3 fatty acids • Nanoparticle drug delivery in the placenta • Adipokines in normal and diabetic pregnancies • Research ethics and governance FACULTY REVIEWS: Jeff Keelan has published the following Faculty Reviews article: Recent advances in the prevention of preterm birth. Keelan JA and Newnham JP. F1000Research 2017, 6(F1000 Faculty Rev):1139 (doi: 10.12688/f1000research.11385.1)